| Dr Lorene Nicole Rodriguez, MD | |
|
5925 Truxtun Ave Ste A, Bakersfield, CA 93309-0433 | |
| (661) 638-2273 | |
| Not Available |
| Full Name | Dr Lorene Nicole Rodriguez |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 5925 Truxtun Ave Ste A, Bakersfield, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053549196 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centric Health | 8729009030 | 54 |
News Archive
Eli Lilly and Company will present early-stage data from several targeted cancer therapies – including bemaciclib "beh meh sye' klib" (LY2835219), its oral, cell-cycle inhibitor of CDK4/6 – that make up its diverse clinical oncology pipeline during the American Association for Cancer Research (AACR) Annual Meeting 2014 held in San Diego, Calif. from April 5 – 9.
Sperm in the first fraction of ejaculate are more numerous, move more and present better quality DNA than those lagging behind. This is the conclusion of a study led by the Ginemed fertility clinic, which confirms that while the objective of the first fraction is to fertilise the egg, the second phase is so that no sperm from any other male has a chance to fertilise it.
ISTA Pharmaceuticals, Inc., today reported financial results for the quarter ended March 31, 2010. First quarter 2010 net revenues were $28.3 million, an increase of 39% from the first quarter of 2009. Net income for the first quarter ended March 31, 2010, was $0.5 million, or $0.01 per share, compared to a net loss of $19.6 million, or $0.59 per share, for the first quarter ended March 31, 2009.
The global effort to quickly develop drugs and vaccines for COVID-19 has been hampered by limited numbers of laboratory mice that are susceptible to infection with SARS-CoV-2, the virus that causes COVID-19.
› Verified 8 days ago
| Entity Name | Centric Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831248236 PECOS PAC ID: 8729009030 Enrollment ID: O20051214000848 |
News Archive
Eli Lilly and Company will present early-stage data from several targeted cancer therapies – including bemaciclib "beh meh sye' klib" (LY2835219), its oral, cell-cycle inhibitor of CDK4/6 – that make up its diverse clinical oncology pipeline during the American Association for Cancer Research (AACR) Annual Meeting 2014 held in San Diego, Calif. from April 5 – 9.
Sperm in the first fraction of ejaculate are more numerous, move more and present better quality DNA than those lagging behind. This is the conclusion of a study led by the Ginemed fertility clinic, which confirms that while the objective of the first fraction is to fertilise the egg, the second phase is so that no sperm from any other male has a chance to fertilise it.
ISTA Pharmaceuticals, Inc., today reported financial results for the quarter ended March 31, 2010. First quarter 2010 net revenues were $28.3 million, an increase of 39% from the first quarter of 2009. Net income for the first quarter ended March 31, 2010, was $0.5 million, or $0.01 per share, compared to a net loss of $19.6 million, or $0.59 per share, for the first quarter ended March 31, 2009.
The global effort to quickly develop drugs and vaccines for COVID-19 has been hampered by limited numbers of laboratory mice that are susceptible to infection with SARS-CoV-2, the virus that causes COVID-19.
› Verified 8 days ago
| Entity Name | Emergency Physicians Urgent Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689963845 PECOS PAC ID: 8527234418 Enrollment ID: O20111227000049 |
News Archive
Eli Lilly and Company will present early-stage data from several targeted cancer therapies – including bemaciclib "beh meh sye' klib" (LY2835219), its oral, cell-cycle inhibitor of CDK4/6 – that make up its diverse clinical oncology pipeline during the American Association for Cancer Research (AACR) Annual Meeting 2014 held in San Diego, Calif. from April 5 – 9.
Sperm in the first fraction of ejaculate are more numerous, move more and present better quality DNA than those lagging behind. This is the conclusion of a study led by the Ginemed fertility clinic, which confirms that while the objective of the first fraction is to fertilise the egg, the second phase is so that no sperm from any other male has a chance to fertilise it.
ISTA Pharmaceuticals, Inc., today reported financial results for the quarter ended March 31, 2010. First quarter 2010 net revenues were $28.3 million, an increase of 39% from the first quarter of 2009. Net income for the first quarter ended March 31, 2010, was $0.5 million, or $0.01 per share, compared to a net loss of $19.6 million, or $0.59 per share, for the first quarter ended March 31, 2009.
The global effort to quickly develop drugs and vaccines for COVID-19 has been hampered by limited numbers of laboratory mice that are susceptible to infection with SARS-CoV-2, the virus that causes COVID-19.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lorene Nicole Rodriguez, MD Po Box 1139, Bakersfield, CA 93302-1139 Ph: (661) 638-2273 | Dr Lorene Nicole Rodriguez, MD 5925 Truxtun Ave Ste A, Bakersfield, CA 93309-0433 Ph: (661) 638-2273 |
News Archive
Eli Lilly and Company will present early-stage data from several targeted cancer therapies – including bemaciclib "beh meh sye' klib" (LY2835219), its oral, cell-cycle inhibitor of CDK4/6 – that make up its diverse clinical oncology pipeline during the American Association for Cancer Research (AACR) Annual Meeting 2014 held in San Diego, Calif. from April 5 – 9.
Sperm in the first fraction of ejaculate are more numerous, move more and present better quality DNA than those lagging behind. This is the conclusion of a study led by the Ginemed fertility clinic, which confirms that while the objective of the first fraction is to fertilise the egg, the second phase is so that no sperm from any other male has a chance to fertilise it.
ISTA Pharmaceuticals, Inc., today reported financial results for the quarter ended March 31, 2010. First quarter 2010 net revenues were $28.3 million, an increase of 39% from the first quarter of 2009. Net income for the first quarter ended March 31, 2010, was $0.5 million, or $0.01 per share, compared to a net loss of $19.6 million, or $0.59 per share, for the first quarter ended March 31, 2009.
The global effort to quickly develop drugs and vaccines for COVID-19 has been hampered by limited numbers of laboratory mice that are susceptible to infection with SARS-CoV-2, the virus that causes COVID-19.
› Verified 8 days ago
May Ling The, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3733 San Dimas St, Bakersfield, CA 93301 Phone: 800-353-5400 | |
Nykia Chichizola-peace, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2400 Wible Rd Ste 14, Bakersfield, CA 93304 Phone: 661-835-1240 | |
Tien Nguyen, M.D Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 4901 Centennial Plaza Way, Bakersfield, CA 93312 Phone: 661-588-1150 Fax: 661-241-4052 | |
Kendall Christine Lubatti, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 8307 Brimhall Rd Ste 1707, Bakersfield, CA 93312 Phone: 661-587-8990 | |
Adan De Jesus Romero Lopez, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9001 South H St, Clinica Sierra Vista, Bakersfield, CA 93307 Phone: 661-328-4260 Fax: 661-617-2881 | |
Tana Sue Parker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7800 Niles St, Bakersfield, CA 93306 Phone: 661-328-4284 Fax: 661-616-9980 | |
Raul Bugnosen, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3733 San Dimas St, Bakersfield, CA 93301 Phone: 800-353-5400 |